stars 1 stars 2 stars 3

Boule Diagnostics develops and manufactures diagnostic instruments and consumables for healthcare providers worldwide. The company’s primary focus is in small to medium-sized hospitals, clinics, and laboratories in both human and veterinary diagnostics. Boule has a strong heritage when it comes to hematology diagnostics. Our blood tests help provide one of the first and most important indicators of a disease state and Boule systems play an increasingly role in helping build the infrastructure of healthcare for small and medium size patient care environments in both human and veterinary diagnostic markets. Boule operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through more than 200 distributors and partners in more than 100 countries, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011

Boule Diagnostics AB Questions

The Boule Diagnostics AB annual revenue was $25 million in 2026.

Yvonne Mårtensson is the Chairwoman of the Board of Boule Diagnostics AB.

82 people are employed at Boule Diagnostics AB.

Boule Diagnostics AB is based in Spånga, Stockholm County.

The NAICS codes for Boule Diagnostics AB are [32599, 33, 32, 325, 325998, 339, 3259].

The SIC codes for Boule Diagnostics AB are [28, 384, 38].

Top Boule Diagnostics AB Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users